Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter Defibrillator
Novel technology recognized for its groundbreaking design and patient-centric innovation
SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a digital wearable platform that monitors and protects high-risk cardiovascular patients, announces that its Jewel® Wearable Patch Cardioverter Defibrillator (Jewel) has received the prestigious Red Dot Design Award. This award signals international recognition of Jewel’s unique design, focusing on patient comfort while delivering continuous protection from temporary periods of elevated Sudden Cardiac Arrest (SCA) risk, which typically occurs in the weeks to months after suffering a cardiac event, such as a heart attack.
The Red Dot Design Award is a globally recognized mark of distinction, celebrating excellence in design and innovation. Jewel’s unique low-profile and water-resistant design redefines wearable defibrillators, addressing the need for compliance and comfort, which are crucial for patients at risk of SCA. This recognition emphasizes Element Science’s commitment to creating life-saving technology that doesn’t interfere with daily activities: https://www.red-dot.org/project/jewel-70050
Dr. Uday N. Kumar, Founder, President, and CEO of Element Science, expressed his gratitude for the award, stating, “Receiving the Red Dot Design Award is a significant milestone for Element Science, reflecting our focus on patient-centered innovation. Jewel combines advanced technology with a discreet design, allowing patients to live their lives while staying protected.”
Jewel offers a set of features designed to increase compliance and effectiveness:
- Continuous Protection from temporary periods of Sudden Cardiac Arrest (SCA) using an advanced machine learning algorithm: Jewel monitors heart rhythms 24/7, alerting patients only when there’s cause for concern, and delivering life-saving defibrillation when needed.
- Comfortable and Discreet: Jewel’s sleek, natural design allows patients to wear it fully concealed under clothing without discomfort, ensuring compliance and minimizing embarrassment.
- Compatible with Daily Activities: Jewel’s water-resistant design means it can be worn during showers and moderate exercise, providing continuous protection while enabling rehabilitation and recovery after cardiac events.
Element Science’s commitment to patient-centered innovation has driven the success of Jewel. The Red Dot Design Award further validates the company’s approach to developing compliant, user-friendly, and life-saving technology.
Dr. Peter Zec, founder and CEO of Red Dot, stated, “The Red Dot Award stands for high design quality and is one of the most prestigious design competitions in the world,” when congratulating Element Science for the win. He continued, “The international jury only awards this sought-after seal of quality to products that feature an outstanding design.” Maarten Dinger, Element Science’s long-standing Head of Design who received the award on behalf of Element Science during the award ceremony in Essen, Germany, said, “We designed a wearable defibrillator that looks and feels like a consumer product, aiming to remove the stigma of being a patient. The Jewel system embodies our human-centric approach, with each touchpoint of the Jewel experience intentionally designed to understand and meet the individual needs of patients, thereby empowering them to live confidently while being protected 24 hours a day.”
As the Company looks forward to commercializing the Jewel, Lee Smith, Jr., Head of Commercial at Element Science, commented on the importance of patient-centric design, stating, “The Red Dot Design Award underscores our commitment to design and innovation that meets the real-world needs of patients. As we plan for the commercialization of Jewel, we believe that its discreet and user-friendly design will play a crucial role in driving its acceptance and success in the market, ultimately improving patient outcomes and enhancing overall adoption of this life-saving technology.”
About the Red Dot Design Award
The Red Dot Design Award is an international design competition that recognizes excellence in three categories — Product Design, Brand and Communication and Design Concept. Awarded annually by a jury of experts in each category, the Red Dot is an acknowledgement of the best in design and business. The coveted “Red Dot” distinction has been the internationally recognized seal of outstanding design quality. A team of experts assess the submissions based on the four basic principles of good design: the quality of function, the quality of seduction, the quality of use, and the quality of responsibility. In 2024, the Red Dot jury is made up of experts from 20 countries on 4 continents, and the entries came from 60 countries.
About the Jewel® Patch Wearable Cardioverter Defibrillator (P-WCD)
Jewel is a novel, water resistant wearable defibrillator designed to detect and treat life-threatening arrhythmias in patients with a temporary elevated risk for SCA. The device continuously monitors a patient’s heart and treats specific life-threatening rhythms. It is designed for continued protection during normal daily activities, including showering, sleeping, and moderate exercise. The Jewel Mobile App enables timely patient care by transmitting therapy information to the patient’s medical team in near real-time.
The Jewel P-WCD is limited to investigational use only and is not available for sale in the United States.
About Element Science, Inc.
Element Science, Inc. is a medical device and digital health company focused on developing solutions at the intersection of clinical-grade wearables, machine learning algorithms, and lifesaving therapies that address leading causes of death and hospitalization in patients with heart disease, primarily as they transition from the hospital-to-home. By putting the needs of patients and physicians first, our personalized digital devices, which are designed for function, comfort, and ease-of-use, aim to redefine the paradigm of care for these patients. Our first product, a wearable patch defibrillator, is initially targeted at treating more than 500,000 patients in the U.S. and Europe with an elevated temporary risk of potentially experiencing a lethal heart rhythm. Based in San Francisco, our funders include Third Rock Ventures, Google Ventures, Deerfield Management, Qiming Venture Partners USA, Cormorant Asset Management, and Invus Opportunities. For more information, please visit www.elementscience.com.
LEARN MORE ABOUT ELEMENT SCIENCE: www.ElementScience.com
Contacts
Sharon N. Buechler
Element Science
650-218-6340
press@elementsci.com
